
ABS Technologies creates dynamic digital twin simulations to transform healthcare. Their models replicate real patient physiology, reflecting diverse populations and a range of health conditions. By integrating computer-driven in-silico trials, they empower hospitals, pharmaceutical companies, and medtech innovators to test treatments from early discovery through clinical phases in a safe, precise, and cost-effective way. The company's technology is built on decades of rigorous scientific research, mathematical modeling, and computational biology, with a focus on neuro-glial-vascular modeling for applications in stroke, neurodegenerative diseases, and gastrointestinal disorders. They aim to deliver a fully integrated, holistic digital twin of the human body to enable personalized healthcare.

ABS Technologies creates dynamic digital twin simulations to transform healthcare. Their models replicate real patient physiology, reflecting diverse populations and a range of health conditions. By integrating computer-driven in-silico trials, they empower hospitals, pharmaceutical companies, and medtech innovators to test treatments from early discovery through clinical phases in a safe, precise, and cost-effective way. The company's technology is built on decades of rigorous scientific research, mathematical modeling, and computational biology, with a focus on neuro-glial-vascular modeling for applications in stroke, neurodegenerative diseases, and gastrointestinal disorders. They aim to deliver a fully integrated, holistic digital twin of the human body to enable personalized healthcare.
Company: Advanced Biosimulation Technologies (ABS Technologies)
Core product: AI-driven digital twin / biosimulation platform for patient-specific in-silico trials
Focus areas: Neuro-glial-vascular modeling, gut–brain axis, stroke and neurodegenerative conditions
Headquarters (registration): North Liberty, Iowa, USA
Notable founder: Dr. Roustem N. Miftahof
Personalized medicine, in-silico clinical trials, physiological simulation for drug and device testing
Digital health / biosimulation
250000.00 USD